Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 743438-45-1
2. Cs 038
3. Carfloglitazar, (s)-
4. E6ejv1j6y0
5. Cs-038
6. L-tyrosine, O-[2-(9h-carbazol-9-yl)ethyl]-n-[2-(4-fluorobenzoyl)phenyl]-
7. (2s)-3-[4-(2-carbazol-9-ylethoxy)phenyl]-2-[2-(4-fluorobenzoyl)anilino]propanoic Acid
8. L-tyrosine, O-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)-
9. (2s)-3-(4-(2-carbazol-9-ylethoxy)phenyl)-2-(2-(4-fluorobenzoyl)anilino)propanoic Acid
10. Unii-e6ejv1j6y0
11. Chembl4650349
12. Schembl22607975
13. Dtxsid00225352
14. Cs038
15. Hy-106266
16. Cs-0025471
17. O-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)-l-tyrosine
Molecular Weight | 572.6 g/mol |
---|---|
Molecular Formula | C36H29FN2O4 |
XLogP3 | 8.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 11 |
Exact Mass | 572.21113557 g/mol |
Monoisotopic Mass | 572.21113557 g/mol |
Topological Polar Surface Area | 80.6 Ų |
Heavy Atom Count | 43 |
Formal Charge | 0 |
Complexity | 895 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?